News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: SENTINEL Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Alexandra J. Lansky November 01, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
Presentation TCT 2016 PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016
Presentation TCT 2016 TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements Presenter: Jean-Claude Laborde, Thomas Walther, Hellmuth Weich October 31, 2016
Presentation TCT 2016 TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv Presenter: John M. Lasala, Philippe Pibarot, Saif Anwaruddin October 31, 2016
Presentation TCT 2016 TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape Presenter: Mayra Guerrero, Roger J. Laham, Yoshio Maeno October 31, 2016
Presentation TCT 2016 TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe October 31, 2016
Presentation TCT 2016 TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVR Experience)Survey Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco October 31, 2016
Presentation TCT 2016 TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco October 31, 2016
Presentation TCT 2016 TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1 Presenter: John M. Lasala, Philippe Pibarot, John Petersen October 31, 2016
Presentation TCT 2016 TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green October 31, 2016
Presentation TCT 2016 A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum October 31, 2016
Presentation TCT 2016 TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith October 31, 2016